Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coherus Oncology (CHRS) Goodwill (2016 - 2023)

Historic Goodwill for Coherus Oncology (CHRS) over the last 10 years, with Q4 2023 value amounting to $943000.0.

  • Coherus Oncology's Goodwill changed 0.0% to $943000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $943000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $943000.0 for FY2023, which is 0.0% changed from last year.
  • Coherus Oncology's Goodwill amounted to $943000.0 in Q4 2023, which was down 0.0% from $943000.0 recorded in Q3 2023.
  • Coherus Oncology's Goodwill's 5-year high stood at $943000.0 during Q1 2019, with a 5-year trough of $900000.0 in Q4 2021.
  • Moreover, its 5-year median value for Goodwill was $943000.0 (2019), whereas its average is $940133.3.
  • Per our database at Business Quant, Coherus Oncology's Goodwill plummeted by 455.99% in 2021 and then soared by 477.78% in 2022.
  • Coherus Oncology's Goodwill (Quarter) stood at $943000.0 in 2019, then changed by 0.0% to $943000.0 in 2020, then dropped by 4.56% to $900000.0 in 2021, then grew by 4.78% to $943000.0 in 2022, then changed by 0.0% to $943000.0 in 2023.
  • Its last three reported values are $943000.0 in Q4 2023, $943000.0 for Q3 2023, and $943000.0 during Q4 2022.